NEW YORK, Oct. 26, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Xerox Corporation ("Xerox" or the "Company") (NYSE: XRX) (ISIN: US9841211033). Investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether Xerox and certain of its officers and/or directors have violated the federal securities laws.

[Click here to join a class action]

On October 26, 2015, pre-market, Xerox reported third quarter 2015 financial results that missed analysts' estimates due in part to lost revenues from the termination of certain of the Company's Health Enterprise segment's projects in California and Montana. The Company explained that the loss of these contracts would result in lower revenues in each of the next three quarters. In addition, Xerox announced that its Board had authorized a strategic review of the Company's entire business portfolio.

On this news, the Company's common stock price fell $0.31 per share, or 3%, to close at $10.03 per share on October 26, 2015.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-xerox-corporation--xrx-300351775.html

SOURCE Pomerantz LLP